Cargando…
Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
INTRODUCTION: People living with HIV (PLHIV) have an elevated risk of atherosclerotic cardiovascular disease (CVD) compared to their HIV‐negative peers. Expanding statin use may help alleviate this burden. However, the choice of statin in the context of antiretroviral therapy is challenging. Pravast...
Autores principales: | Boettiger, David C, Newall, Anthony T, Chattranukulchai, Pairoj, Chaiwarith, Romanee, Khusuwan, Suwimon, Avihingsanon, Anchalee, Phillips, Andrew, Bendavid, Eran, Law, Matthew G, Kahn, James G, Ross, Jeremy, Bautista‐Arredondo, Sergio, Kiertiburanakul, Sasisopin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305414/ https://www.ncbi.nlm.nih.gov/pubmed/32562359 http://dx.doi.org/10.1002/jia2.25494 |
Ejemplares similares
-
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis
por: Boettiger, David C., et al.
Publicado: (2021) -
A Prediction Model of Pretreatment HIV RNA Levels in Naïve Thai HIV-infected Patients: An Application for Resource-limited Settings
por: Pongpech, Nisha, et al.
Publicado: (2017) -
The Safety of Substitution of Antiretroviral Regimen in Non-Clinical Trial Settings in Asian Countries
por: Jung, In Young, et al.
Publicado: (2017) -
The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD)
por: Jung, In Young, et al.
Publicado: (2017) -
Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)